Neurostim device weans patients off ventilators To view this email as a web page,
click here Fauci: U.S. needs to boost vaccinations to stay ahead in race against COVID-19 variants Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss Neurostim device nets FDA breakthrough label to wean COVID-19 patients off ventilators Fujifilm takes its CDMO power play to the Tarheel State with plans for $2B plant VIDEO: It's been a year. So, when did you realize the world was going to change? House passes bill to grant nine-month extension to a moratorium on Medicare payment sequester cuts COVID-19 tracker: U.S. to send AZ vaccines to Mexico, Canada; Europe facing third wave Featured Story | By Robert King Anthony Fauci told a Senate panel that the U.S. is in a race to vaccinate more people to hold off the spread of emerging variants of COVID-19. read more |
| |
|---|
|
Top Stories By Eric Sagonowsky Like a host of other companies, Incyte has been testing one of its existing meds against COVID-19—and that drug, Jakafi, has now fallen short in a phase 3 trial. But the company is forging ahead, saying the new data show enough promise to make the cancer med a viable option for severely ill COVID patients. read more By Conor Hale The FDA granted a breakthrough designation to a neurostimulation device designed to strengthen the diaphragm and help wean people who are having difficulty breathing on their own off of mechanical ventilation. read more By Kevin Dunleavy In Holly Springs, North Carolina, Fujifilm will invest more than $2 billion to build the largest cell culture biopharmaceutical CDMO facility in North America. read more By Tina Reed Fierce Healthcare recently chatted with leaders around the industry about when they first realized the COVID-19 pandemic was going to change everything. read more By Robert King The House passed a bill that gives another extension to a moratorium on a 2% cut to Medicare provider payments installed under sequestration. read more By Kevin Dunleavy,Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale The U.S. will send some of its unused AZ vaccine stock to Mexico and Canada. With Europe facing a third coronavirus wave, Germany and France tighten restrictions. Stelis of India will manufacture 200 million doses of the Sputnik V vaccine. read more |
|
